Correction: Retraction: Stiffening-induced high pulsatility flow activates endothelial inflammation via a TLR2/NF-κB pathway(PLoS ONE (2019)9:7 (e102195)Doi:10.1371/journal.pone.0102195);Stiffening-induced high pulsatility flow activates endothelial inflammation via a TLR2/NF-κB pathway

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Tan, Yan ^a,b,c   Tseng, Pi Ou ^a   Wang, Daren ^b   Zhang, Hui ^b,d   Hunter, Kendall ^b   Hertzberg, Jean ^a   Stenmark, Kurt R ^b   Tan, Wei ^a  

^a University of Colorado at Boulder   (United States)

^b University of Colorado Denver and Children s Hospital Colorado   (United States)

^c FIRST MILITARY MEDICAL UNIVERSITY   (China)

^d CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; VASCULAR CELL ADHESION MOLECULE 1; OXIDIZED-L-ALPHA-1-PALMITOYL-2-ARACHIDONOYL-SN-GLYCERO-3-PHOSPHORYLCHOLINE; PHOSPHATIDYLCHOLINE;

ANIMAL CELL; ARTERIAL STIFFNESS; ARTERY ENDOTHELIUM; ARTICLE; CATTLE; CELL CULTURE; CHILD; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE SILENCING; HEART OUTPUT; HUMAN; IN VITRO STUDY; INFLAMMATION; MALE; MOLECULAR MECHANICS; NONHUMAN; PROTEIN EXPRESSION; PULMONARY ARTERY; PULSATILE FLOW; SIGNAL TRANSDUCTION; YOUNG MODULUS; ANIMAL; ANTAGONISTS AND INHIBITORS; BOVINAE; DEFICIENCY; DRUG EFFECTS; GENETICS; MECHANOTRANSDUCTION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PULMONARY HYPERTENSION; UPREGULATION;

ANIMALS; CATTLE; ENDOTHELIAL CELLS; GENE KNOCKDOWN TECHNIQUES; HYPERTENSION, PULMONARY; INFLAMMATION; MECHANOTRANSDUCTION, CELLULAR; NF-KAPPA B; PHOSPHATIDYLCHOLINES; PULSATILE FLOW; RNA, SMALL INTERFERING; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; UP-REGULATION; VASCULAR STIFFNESS;

EID: 84904350882     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0221184     Document Type: Erratum

References (40)

1. Adji A, O'Rourke MF, Namasivayam M (2011) Arterial stiffness, its assessment, prognostic value, and implications for treatment. Am J Hypertens 24: 5-17.
2. Hashimoto J, Ito S (2011) Central pulse pressure and aortic stiffness determine renal hemodynamics: pathophysiological implication for microalbuminuria in hypertension. Hypertension 58: 839-846.
3. Mitchell GF, van Buchem MA, Sigurdsson S, Gotal JD, Jonsdottir MK, et al. (2011) Arterial stiffness, pressure and flow pulsatility and brain structure and function: the Age, Gene/Environment Susceptibility-Reykjavik study. Brain 134: 3398-3407.
4. Lammers S, Scott DE, Hunter K, Tan W, Shandas R, et al. (2012) Mechanics and function of the pulmonary vasculature: Implications for pulmonary vascular disease and right ventricular function. Compr Physiol 1: 1-25.
5. Zachariah JP, Xanthakis V, Larson MG, Vita JA, Sullivan LM, et al. (2012) Circulating vascular growth factors and central hemodynamic load in the community. Hypertension 59: 773-779.
6. Wang Z, Chesler NC (2011) Pulmonary vascular wall stiffness: An important contributor to the increased right ventricular afterload with pulmonary hypertension. Pulm Circ 1: 212-223.
7. Burton A, editor (1966) Physiology and biophysics of the circulation. Chicago: Year Book.
8. Chiu RCJ (1995) Biophysics of pulsatile perfusion. J Thorac Cardiovas Surg 109: 810.
9. Chiu JJ, Chien S (2011) Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiological reviews 91: 327-387.
10. Davies PF (2009) Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology. Nature clinical practice Cardiovascular medicine 6: 16-26.
11. Hahn C, Schwartz MA (2009) Mechanotransduction in vascular physiology and atherogenesis. Nature reviews Molecular cell biology 10: 53-62.
12. Li M, Scott DE, Shandas R, Stenmark KR, Tan W (2009) High pulsatility flow induces adhesion molecule and cytokine mRNA expression in distal pulmonary artery endothelial cells. Ann Biomed Eng 37: 1082-1092.
13. Curtiss LK, Tobias PS (2009) Emerging role of Toll-like receptors in atherosclerosis. J Lipid Res 50 Suppl: S340-345.
14. Dunzendorfer S, Lee HK, Tobias PS (2004) Flow-dependent regulation of endothelial Toll-like receptor 2 expression through inhibition of SP1 activity. Circ Res 95: 684-691. (Pubitemid 39331928)
15. Li X, Jiang S, Tapping RI (2010) Toll-like receptor signaling in cell proliferation and survival. Cytokine 49: 1-9.
16. Erridge C (2009) The roles of Toll-like receptors in atherosclerosis. J Innate Immun 1: 340-349.
17. Tian L, Lammers SR, Kao PH, Reusser M, Stenmark KR, et al. (2011) Linked opening angle and histological and mechanical aspects of the proximal pulmonary arteries of healthy and pulmonary hypertensive rats and calves. Am J Physiol Heart Circ Physiol 301: H1810-1818.
18. Lau EM, Iyer N, Ilsar R, Bailey BP, Adams MR, et al. (2012) Abnormal pulmonary artery stiffness in pulmonary arterial hypertension: in vivo study with intravascular ultrasound. PLoS One 7: e33331.
19. Sanz J, Kariisa M, Dellegrottaglie S, Prat-Gonzalez S, Garcia MJ, et al. (2009) Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. JACC Cardiovasc Imaging 2: 286-295.
20. Hunter KS, Albietz JA, Lee PF, Lanning CJ, Lammers SR, et al. (2010) In vivo measurement of proximal pulmonary artery elastic modulus in the neonatal calf model of pulmonary hypertension: development and ex vivo validation. J Appl Physiol 108: 968-975.
21. Grignola JC, Domingo E, Aguilar R, Vazquez M, Lopez-Messeguer M, et al. (2011) Acute absolute vasodilatation is associated with a lower vascular wall stiffness in pulmonary arterial hypertension. Int J Cardiol.
22. Paz R, Mohiaddin RH, Longmore DB (1993) Magnetic resonance assessment of the pulmonary arterial trunk anatomy, flow, pulsatility and distensibility. Eur Heart J 14: 1524-1530. (Pubitemid 24002717)
23. Reuben SR (1971) Compliance of the human pulmonary arterial system in disease. Circ Res 29: 40-50.
24. Li M, Scott DE, Shandas R, Stenmark KR, Tan W (2009) High pulsatility flow induces adhesion molecule and cytokine mRNA expression in distal pulmonary artery endothelial cells. Ann Biomed Eng 37: 1082-1092.
25. Stenmark KR, McMurtry IF (2005) Vascular remodeling versus vasoconstriction in chronic hypoxic pulmonary hypertension: a time for reappraisal? Circ Res 97: 95-98. (Pubitemid 41033463)
26. Peng X, Haldar S, Deshpande S, Irani K, Kass DA (2003) Wall stiffness suppresses Akt/eNOS and cytoprotection in pulse-perfused endothelium. Hypertension 41: 378-381. (Pubitemid 36204918)
27. McCarthy CG, Goulopoulou S, Wenceslau CF, Spitler K, Matsumoto T, et al. (2014) Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension. American journal of physiology Heart and circulatory physiology 306: H184-196.
28. Mian MO, Paradis P, Schiffrin EL (2014) Innate immunity in hypertension. Current hypertension reports 16: 413.
29. Singh MV, Chapleau MW, Harwani SC, Abboud FM (2014) The immune system and hypertension. Immunologic research.
30. Spirig R, Tsui J, Shaw S (2012) The Emerging Role of TLR and Innate Immunity in Cardiovascular Disease. Cardiology research and practice 2012: 181394.
31. Bogaard HJ, Natarajan R, Henderson SC, Long CS, Kraskauskas D, et al. (2009) Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure. Circulation 120: 1951-1960.
32. Erridge C (2010) Endogenous ligands of TLR2 and TLR4: agonists or assistants? Journal of leukocyte biology 87: 989-999.
33. Hochleitner BW, Hochleitner EO, Obrist P, Eberl T, Amberger A, et al. (2000) Fluid shear stress induces heat shock protein 60 expression in endothelial cells in vitro and in vivo. Arteriosclerosis, thrombosis, and vascular biology 20: 617-623. (Pubitemid 30151672)
34. Pryshchep O, Ma-Krupa W, Younge BR, Goronzy JJ, Weyand CM (2008) Vessel-specific Toll-like receptor profiles in human medium and large arteries. Circulation 118: 1276-1284.
35. Mullick AE, Soldau K, Kiosses WB, Bell TA 3rd, Tobias PS, et al. (2008) Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events. J Exp Med 205: 373-383. (Pubitemid 351281603)
36. Jang HJ, Kim HS, Hwang DH, Quon MJ, Kim JA (2013) Toll-like receptor 2 mediates high-fat diet-induced impairment of vasodilator actions of insulin. American journal of physiology Endocrinology and metabolism 304: E1077-1088.
37. Bertocchi C, Traunwieser M, Dorler J, Hasslacher J, Joannidis M, et al. (2011) Atorvastatin inhibits functional expression of proatherogenic TLR2 in arterial endothelial cells. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 28: 625-630.
38. Higashikuni Y, Tanaka K, Kato M, Nureki O, Hirata Y, et al. (2013) Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1beta upregulation via nuclear factor kappaB activation. Journal of the American Heart Association 2: e000267.
39. Bauer EM, Chanthaphavong RS, Sodhi CP, Hackam DJ, Billiar TR, et al. (2014) Genetic deletion of toll-like receptor 4 on platelets attenuates experimental pulmonary hypertension. Circulation research 114: 1596-1600.
40. Broen JC, Bossini-Castillo L, van Bon L, Vonk MC, Knaapen H, et al. (2011) A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators. Arthritis Rheum 64: 264-271.